These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33962088)

  • 1. Structure-based design approach of potential BCL-2 inhibitors for cancer chemotherapy.
    Krishna S; Kumar SB; Murthy TPK; Murahari M
    Comput Biol Med; 2021 Jul; 134():104455. PubMed ID: 33962088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigallocatechin gallate and curcumin inhibit Bcl-2: a pharmacophore and docking based approach against cancer.
    Bahadar N; Bahadar S; Sajid A; Wahid M; Ali G; Alghamdi A; Zada H; Khan T; Ullah S; Sun Q
    Breast Cancer Res; 2024 Jul; 26(1):114. PubMed ID: 38978121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide screening to knockdown Bcl-2's anti-apoptotic activity: implications in cancer treatment.
    Raghav PK; Verma YK; Gangenahalli GU
    Int J Biol Macromol; 2012 Apr; 50(3):796-814. PubMed ID: 22155216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding affinity of pro-apoptotic BH3 peptides for the anti-apoptotic Mcl-1 and A1 proteins: Molecular dynamics simulations of Mcl-1 and A1 in complex with six different BH3 peptides.
    Modi V; Sankararamakrishnan R
    J Mol Graph Model; 2017 May; 73():115-128. PubMed ID: 28279820
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Gowtham HG; Ahmed F; Anandan S; Shivakumara CS; Bilagi A; Pradeep S; Shivamallu C; Shati AA; Alfaifi MY; Elbehairi SEI; Achar RR; Silina E; Stupin V; Murali M; Kollur SP
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-based design approach of potential Bcl-2 inhibitors for cancer chemotherapy.
    Arakal NG; Sharma V; Kumar A; Kavya B; Devadath NG; Kumar SB; Murthy KT; Murahari M
    Comput Methods Programs Biomed; 2021 Sep; 209():106347. PubMed ID: 34399152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
    Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
    J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deciphering the crucial molecular properties of a series of Benzothiazole Hydrazone inhibitors that targets anti-apoptotic Bcl-xL protein.
    Marimuthu P; Balasubramanian PK; Singaravelu K
    J Biomol Struct Dyn; 2018 Aug; 36(10):2654-2667. PubMed ID: 28793831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current overview on the clinical update of Bcl-2 anti-apoptotic inhibitors for cancer therapy.
    Suvarna V; Singh V; Murahari M
    Eur J Pharmacol; 2019 Nov; 862():172655. PubMed ID: 31494078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deciphering the crucial residues involved in heterodimerization of Bak peptide and anti-apoptotic proteins for apoptosis.
    Marimuthu P; Singaravelu K
    J Biomol Struct Dyn; 2018 May; 36(6):1637-1648. PubMed ID: 28511583
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Almansour NM; Allemailem KS; Abd El Aty AA; Ismail EIF; Ibrahim MAA
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteins of the bcl-2 family in apoptosis signalling: from mechanistic insights to therapeutic opportunities.
    Chan SL; Yu VC
    Clin Exp Pharmacol Physiol; 2004 Mar; 31(3):119-28. PubMed ID: 15008953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand- and structure-based in silico studies to identify kinesin spindle protein (KSP) inhibitors as potential anticancer agents.
    Balakumar C; Ramesh M; Tham CL; Khathi SP; Kozielski F; Srinivasulu C; Hampannavar GA; Sayyad N; Soliman ME; Karpoormath R
    J Biomol Struct Dyn; 2018 Nov; 36(14):3687-3704. PubMed ID: 29064326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel Plasmodium falciparum PI4KB inhibitors as potential anti-malarial drugs: Homology modeling, molecular docking and molecular dynamics simulations.
    Ibrahim MAA; Abdelrahman AHM; Hassan AMA
    Comput Biol Chem; 2019 Jun; 80():79-89. PubMed ID: 30928871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between helix stability and binding affinities: molecular dynamics simulations of Bfl-1/A1-binding pro-apoptotic BH3 peptide helices in explicit solvent.
    Modi V; Lama D; Sankararamakrishnan R
    J Biomol Struct Dyn; 2013; 31(1):65-77. PubMed ID: 22803956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating Ligand and Target-Driven Based Virtual Screening Approaches With
    Tutumlu G; Dogan B; Avsar T; Orhan MD; Calis S; Durdagi S
    Front Chem; 2020; 8():167. PubMed ID: 32328476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Bcl-2 in tumour cell survival and implications for pharmacotherapy.
    Tomek M; Akiyama T; Dass CR
    J Pharm Pharmacol; 2012 Dec; 64(12):1695-702. PubMed ID: 23146031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shedding Light on the Interaction of Human Anti-Apoptotic Bcl-2 Protein with Ligands through Biophysical and in Silico Studies.
    Ramos J; Muthukumaran J; Freire F; Paquete-Ferreira J; Otrelo-Cardoso AR; Svergun D; Panjkovich A; Santos-Silva T
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Novel Potential gp120 of HIV-1 Antagonist Using Per-Residue Energy Contribution-Based Pharmacophore modelling.
    Berinyuy E; Soliman MES
    Interdiscip Sci; 2017 Sep; 9(3):406-418. PubMed ID: 27165479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A delicate balance - The BCL-2 family and its role in apoptosis, oncogenesis, and cancer therapeutics.
    Knight T; Luedtke D; Edwards H; Taub JW; Ge Y
    Biochem Pharmacol; 2019 Apr; 162():250-261. PubMed ID: 30668936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.